Description
The skeptic noted AhR is promiscuous with dozens of ligands, but the mechanistic specificity of TMAO-AhR signaling remains unestablished. Understanding competitive binding and pathway selectivity is essential for therapeutic targeting.
Source: Debate session sess_SDA-2026-04-16-gap-20260416-121711_20260416-134918 (Analysis: SDA-2026-04-16-gap-20260416-121711)